Table 1. Participant's clinical background.
group | Continuous aerobic training (n = 15) |
Super-circuit training (n = 14 |
|
---|---|---|---|
n (%) | n (%) | ||
Pharmacological treatment | Beta-blockers | 10 (66.7) | 8 (57.1) |
An angiotensin-converting-enzyme inhibitor | 8 (81) | 10 (71.4) | |
Diuretics | 3 (24.0) | 4 (28.6) | |
Statins | 10 (76.7) | 12 (85.7) | |
Anti-coagulations | 5 (33.3) | 5 (35.7) | |
Co-morbidities | Diabetes mellitus | 5 (33.3) | 3 (21.4) |
Hypertension | 8 (53.3) | 8 (57.1) | |
Obesity | 4 (26.7) | 3 (21.4) |